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Therapeutic cancer vaccines are an attractive alternative to
conventional therapies to treat malignant tumors, and
more importantly, to prevent recurrence after primary
therapy. However, the availability of professional antigen-
presenting cells (APCs) has been restricted by difficulties
encountered in obtaining sufficient professional APCs for
clinical use. We have prepared an alternative cellular vac-
cine with CD4 T cells that can be expanded easily to yield
a pure and homogeneous population in vitro. To enhance
their potency as a therapeutic vaccine, in vitro expanded
CD4 T cells were transfected with RNAs encoding the
costimulatory ligands CD80, 4-1BBL, or both (CD80-T,
4-1BBL-T, and CD80/4-1BBL-T cells, respectively). We
observed augmented cell vitality in CD80/4-1BBL-T cells
in vitro and in vivo. Significant CD8 T cell responses elicit-
ing in vivo proliferation and cytotoxicity were obtained
with CD80/4-1BBL-T cell vaccination compared to
CD80-T and 4-1BBL-T cell vaccinations. Furthermore,
CD80/4-1BBL-T cell immunization resulted in curing
established EG7 tumors, resulting in the generation of
memory CD8 T cell responses, and elicited therapeutic
antitumor responses against B16 melanoma. These results
suggest that CD4 T cells endowed with costimulatory
ligands allow the design of effective vaccination strategies
against cancer.
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